Patient by nature
She backs founders early and stays with them through the long work of building.
Investing · Published 25 May 2026
How Nicole Junkermann Thinks About Investing in Healthcare
A look at the principles behind her approach: patience, evidence, trust and a long-term commitment to founders building something that matters.
In healthcare, the best investments are patient ones, built on evidence and trust rather than noise.
Through NJF Holdings and its venture capital arm NJF Capital, Nicole Junkermann has backed companies across artificial intelligence, healthtech, biotech, fintech and deep technology. Healthcare holds a special place in that work, because it sits closest to the principle she returns to most often: that the most exciting technology is the kind that helps people live healthier lives. This is a look at how Nicole Junkermann thinks about investing in this field, and the qualities she looks for before she commits.
Patient capital
The first thing to understand about the approach of Nicole Junkermann is that it is patient. She tends to back founders early and stay with them as they grow, rather than chasing quick wins. Healthcare rewards this temperament. Good health products are not built in a sprint; they require careful evidence, regulatory care and the slow accumulation of trust. Investing with patience means giving founders the room to do that properly, and resisting the pressure to rush something sensitive to market before it is ready.
A real clinical need
Before anything else, Nicole Junkermann asks whether a company answers a genuine clinical need. The most durable health businesses solve a real problem for real patients or clinicians, not a manufactured one dressed up in a pleasing interface. A clear need gives a company its sense of direction and its reason to exist. Where that need is strongest, often in areas that have been overlooked, the potential to do good and to build something valuable point in the same direction, which is exactly the kind of alignment she looks for.
Evidence over enthusiasm
Enthusiasm is easy; evidence is harder and far more important. Nicole Junkermann wants to see that a product is built on sound science and tested thinking rather than a compelling story alone. In health, the stakes are high, and claims have to be earned. She is drawn to teams that respect that discipline, that measure honestly and that are willing to let the evidence shape the product. This rigour is not a brake on ambition; it is what makes ambition trustworthy.
Trust and privacy as fundamentals
Because health involves some of the most personal information there is, Nicole Junkermann treats privacy as a fundamental rather than a feature to add later. She looks for companies that are clear about what they collect, generous with control and plain in their language. In health, trust is the real product, and the businesses that respect that earn genuine, lasting loyalty. A careless attitude to data is, for her, a clear warning sign, however impressive the technology might otherwise be.
Founders who build for the long term
People matter as much as ideas. Nicole Junkermann is drawn to founders who understand their clinical problem deeply, who think in years rather than months, and who are motivated by the difference their work can make. The long, patient process of building in healthcare suits people with conviction and stamina, and she sees her role as supporting them through it. Backing the right founders early, and staying alongside them, is at the heart of how she invests.
The power of artificial intelligence, used responsibly
As an active investor in artificial intelligence, Nicole Junkermann is especially interested in how it can strengthen healthcare, from speeding up research to turning complex results into clear insight. But she is clear-eyed about doing it responsibly: the aim is to support clinicians and patients, not to replace human judgement. The companies she finds most promising treat artificial intelligence as a capable assistant working within careful limits. She explores this in Nicole Junkermann on AI and the future of medicine.
Diversification with conviction
Although healthcare holds a special place in her work, Nicole Junkermann invests across artificial intelligence, healthtech, biotech, fintech and deep technology, and she sees real value in that breadth. Working across several fields gives her a wider view of how ideas travel, so an advance in data science or finance can inform how she thinks about a health company, and the other way around. At the same time, she pairs that breadth with conviction: when she believes in a founder, she commits and stays the course. The combination of a wide lens and a steady hand suits a field where the most important results often take years to arrive.
Patience with the regulatory journey
One thing Nicole Junkermann is realistic about is that healthcare moves carefully for good reason. The processes that protect patients, from clinical evidence to careful oversight, take time, and she sees that as a feature rather than a frustration. Founders who respect the journey, who plan for it and build trust with the people who use their products, tend to create companies that endure. Rushing a sensitive health product to market, in her view, is rarely worth the risk, and the patience she brings as an investor is partly about giving teams room to get these important steps right.
Looking for impact that lasts
Ultimately, Nicole Junkermann measures a healthcare investment by the lives it can improve. The areas that draw her most are often those that have been under-served, where progress can change a great many lives, including women's health, which she writes about in closing the women's health gap. The companies she backs tend to share a spirit she values across all her work: build with attention, evidence, clarity and kindness, and the impact, and the value, will follow. To read more, see the femtech founders Nicole Junkermann admires or the profile of Nicole Junkermann.
Evidence first
In health, claims must be earned; sound science matters more than a good story.
Impact that lasts
The truest measure of an investment is the number of lives it improves.
Frequently asked questions
How does Nicole Junkermann approach investing in healthcare?
Nicole Junkermann invests with patience, backing founders early and staying with them, and looks for real clinical need, strong evidence, respect for privacy and long-term thinking.
What does Nicole Junkermann look for in a healthcare founder?
Nicole Junkermann looks for founders who understand the clinical problem deeply, build on evidence, treat data with respect and are committed to the long, patient work that good health products require.
What does Nicole Junkermann invest in?
Nicole Junkermann invests in healthtech, biotech, artificial intelligence, fintech and deep technology through NJF Holdings and its venture capital arm NJF Capital.
Keep reading: the health innovations Nicole Junkermann is watching, why Nicole Junkermann believes in femtech, or browse the Wellbeing Tech section.